fbpx

Safilo Group: Q3 and First 9 Months of 2019 Trading Update

The Board of Directors of Safilo Group has reviewed and approved Q3 and first 9 months 2019 economic and financial key performance indicators.

Angelo Trocchia, Safilo Chief Executive Officer, commented: “In the third quarter of the year, we continued the improvement of our results, working with determination on those priorities aimed at enhancing our Group’s assets, in particular strengthening our commercial capabilities and enhancing our digital agenda, two areas in which our strategy is focused on the customer and on a continuous and ever closer connection with the final consumer. Meanwhile, we progressed also with actions to improve the efficiency of our production processes and overhead cost structures.

The quarter brought significant results, we renewed two strategic partnerships relating to the Boss and Hugo licenses and the supply agreement with Kering Eyewear, and we prepared for the launch of our new licenses David Beckham, Levi’s and Missoni. While we move into a complex business and industry context in which we plan for the medium and long term to build top and bottom line, the quarter is indeed a further confirmation of the quality of the work we undertook, both in terms of top line, with our core wholesale1 business improving by 2.8% at constant exchange rates, as well on the economic front, achieving an adjusted2 EBITDA of Euro 9.7 million. We look at the current year as a transition year for building the foundation to face the challenges and opportunities that lie ahead.”

Safilo closed the first 9 months of 2019 with the net sales of the Continuing Operations at €708.7 million, up 5.2% at current exchange rates and 2.7% at constant exchange rates. The performance was positively influenced by a 3.2% growth of the European market, and by the recovery of the main emerging markets, particularly significant in Asia Pacific which ended up 22.5%. Turnover was down 2.0% at constant exchange rates in North America.

The wholesale business increased by 6.4% at current exchange rates and by 3.7% at constant exchange rates, with Europe up 5.6%.

The North American business, on the other hand, recorded a 7.7% drop at constant exchange rates, mainly reflecting the consolidation of all the North American logistic activities in the new Denver warehouse, a start-up temporarily affecting the performance of Smith sport products.

The quarterly performance also confirmed the good growth of the Carrera and Polaroid brands and the positive trends of the main licensed brands.

Click HERE for the full press release.

Featured Posts

EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read More
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read More
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read More
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read More
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more